ClinicalTrials.gg
CompletedNCT03344354InDureUpdated Aug 22, 2023

Durability of Double-gloving With Biogel® Surgical Gloves When Used by Clinicians/Surgeons

An interventional study of Biogel and Ansell in Gloves, Surgical, sponsored by Molnlycke Health Care AB. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-08-22.

Sponsored by Molnlycke Health Care AB · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was Nov 2021, 4 years 11 months ago, and no results have been posted to the registry.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
3,507
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A prospective open-label study design was chosen because it will provide the most accurate data on the efficacy of four commercially available similar brands of NRL (natural rubber latex) and synthetic latex surgical gloves when they are used for surgeries in a clinical setting. The primary endpoint will be the overall failure rate of the Biogel® sterile surgical undergloves (device) compared to three undergloves brands of surgical gloves. The secondary endpoints are perforation rates of the underglove, the failure rate of the overglove, the frequency of overglove perforation detection by the glove wearer when double-gloving, the ratio of perforations detected of overglove compared to underglove and to determine the frequency of overglove perforation detection by the glove wearer.

The clinical investigation will be statistically powered to test the hypothesis that the failure rate of the Biogel® Sterile Surgical undergloves is different from that of the three comparators.

Read the detailed description

This is a non-significant risk, cross-over, comparative, prospective, five-armed, open-label clinical investigation in which the perforation rate of surgical gloves from four different manufacturers will be evaluated in double-gloving fashion. Study clinicians who will directly in the sterile field, with a similar surgical procedural work scope will be asked to use gloves from the four manufacturers of surgical gloves while performing surgical procedures. The types of procedures under which the study gloves will be put in use are prosthetic joints arthroplasty and implantation (i.e. orthopedic), trauma surgery, neurosurgery, colorectal and cardiothoracic surgery.

All gloves under evaluation in each phase will be assessed for perforation rate and overall failure on the basis of binomial responses (Y/N) looking at five time points:

  • glove failure pre-donning (after removal from pack, prior to donning)
  • glove failure during donning (putting the gloves on)
  • observed intraoperative glove failure
  • glove failure during doffing (glove removal)
  • post-procedure: glove perforation and failure determined using a standardized water leak test

No patients have been enrolled in this study therefore no patient data will be assessed.

02

Conditions studied

  • Gloves, Surgical
03

In context

Lead sponsor

Molnlycke Health Care AB is the lead sponsor of 59 studies on the registry; 8 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 3 (38%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All study clinicians, i.e. study glove wearers, must meet all of the following Inclusion Criteria in order to be included in the investigation:

  • Must be certified and licensed physician or a clinician in training under supervision in Orthopedic, Neurosurgery, Cardiothoracic, Colorectal or Trauma specialty surgery services or be working in other OR support functions;
  • Directly take part in the surgical procedure work within the sterile field;
  • Be willing to wear half size larger underglove if recommended by the manufacturer.
  • Perform one of the five target procedure groups which is scheduled to last a minimum of 1 hour;
  • Be a current employee or active medical staff member with privileges at the institution conducting the clinical investigation;
  • Be willing and able to participate in the written user survey and other tasks associated with the clinical investigation and evaluation of the surgical gloves;
  • Be willing and able to read, understand and sign the participant information and consent form prior to the initiation of the clinical investigation.

Exclusion criteria

Exclusion Criteria:

All potential study participants who meets any of the following Exclusion Criteria will not be included in the investigation:

  • Has had or currently has dermatological or other medical conditions that may prevent proper scrub technique and the use of the sterile study surgical gloves for the duration of the participation in the procedure or the span of time the investigation is to take place;
  • Wearing of rings, bracelets, or other jewelry that cannot be removed during glove evaluation;
  • Incomplete or absent training on the current clinical investigation plan and study participation responsibilities; and
  • Is an employee or staff member of the Sponsor, CRO or any other glove manufacturer; or is an immediate relative of an employee of the Sponsor, CRO or any other glove manufacturer.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
3,507 participants (actual)

Study arms

  • Active comparator
    Brand 1

    sterile surgical gloves Two arms of Brand 1 were combined to allow comparison of the total of all comparator gloves.

    Device: Biogel

  • Active comparator
    Brand 2

    sterile surgical gloves

    Device: Ansell

  • Active comparator
    Brand 3

    sterile surgical gloves

    Device: Cardinal

  • Active comparator
    Brand 4

    sterile sergical gloves

    Device: Medline

Interventions

  • DeviceBiogel

    Sterile surgical gloves used during surgical procedures.

  • DeviceAnsell

    Sterile surgical gloves used during surgical procedures.

  • DeviceCardinal

    Sterile surgical gloves used during surgical procedures.

  • DeviceMedline

    Sterile surgical gloves used during surgical procedures.

06

What researchers measure

Primary outcomes

  1. Underglove failure rate compared between all competitors

    To determine and compare the failure rate of the Biogel® natural rubber latex (NRL) and synthetic latex study underglove assortment to all competitors combined as non-Biogel.

    Time frame: Procedures that are scheduled to last a minimum of one (1) hour long

  2. Underglove failure rate compared to each of the three comparators

    To determine and compare the failure rate of the Biogel® natural rubber latex (NRL) and synthetic latex study underglove assortment to each of the three comparators.

    Time frame: Procedures that are scheduled to last a minimum of one (1) hour long

Secondary outcomes

  1. Underglove perforation rate compared to each of the three comparators comparators separately and combined as non-Biogel.

    To determine and compare the perforation rate of the Biogel® NRL and synthetic latex study underglove assortment to that of the three comparators separately and combined as non-Biogel.

    Time frame: Procedures that are scheduled to last a minimum of one (1) hour long

07

Study locations

1 site
  • Virginia Commonwealth University
    Richmond, Virginia 23298, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2018 to primary completion in Nov 2021, 43 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2017
First posted
Nov 17, 2017
StartActual
Apr 10, 2018
Primary completionActual
Nov 18, 2021
CompletionActual
Oct 26, 2022
Last update
Aug 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03344354
Responsible party
Sponsor
First posted
Nov 17, 2017
Start date
Apr 10, 2018
Primary completion
Nov 18, 2021
Completion
Oct 26, 2022
Last update
Aug 22, 2023

Study contacts

Michelle Doll, MD, MPH
principal investigator · Virginia Commonwealth University Health
Gonzalo M.L. Bearman
principal investigator · Virginia Commonwealth University Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion